IRONWOOD PHARMACEUTICALS INC's ticker is IRWD and the CUSIP is 46333X108. A total of 250 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.84 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $12,614,000 | -58.2% | 825,000 | -56.6% | 0.23% | -56.9% |
| Q3 2016 | $30,172,000 | -23.1% | 1,900,000 | -36.7% | 0.54% | -29.8% |
| Q2 2016 | $39,225,000 | +32.3% | 3,000,000 | +10.7% | 0.77% | +32.8% |
| Q1 2016 | $29,647,000 | +8.8% | 2,710,000 | +15.3% | 0.58% | +1.9% |
| Q4 2015 | $27,237,000 | +37.6% | 2,350,000 | +23.7% | 0.57% | +11.5% |
| Q3 2015 | $19,798,000 | +13.2% | 1,900,000 | +31.0% | 0.51% | +60.3% |
| Q2 2015 | $17,487,000 | +21.4% | 1,450,000 | +61.1% | 0.32% | +17.2% |
| Q1 2015 | $14,400,000 | +88.0% | 900,000 | +80.0% | 0.27% | +58.7% |
| Q4 2014 | $7,660,000 | +237.9% | 500,000 | +185.7% | 0.17% | +230.8% |
| Q3 2014 | $2,267,000 | -10.4% | 175,000 | +6.1% | 0.05% | 0.0% |
| Q2 2014 | $2,529,000 | – | 165,000 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HealthInvest Partners AB | 1,520,000 | $19,562,000 | 18.54% |
| Sarissa Capital Management LP | 16,390,000 | $210,939,000 | 16.77% |
| Healthcare Value Capital, LLC | 200,000 | $2,574,000 | 5.13% |
| Camber Capital Management LP | 7,500,000 | $96,525,000 | 3.25% |
| 13D Management LLC | 650,455 | $8,371,000 | 2.88% |
| BRIDGER MANAGEMENT, LLC | 2,035,114 | $26,192,000 | 2.44% |
| Brown Capital Management | 18,484,759 | $237,899,000 | 1.80% |
| Healthcare Value Capital, LLC | 50,000 | $644,000 | 1.28% |
| Zebra Capital Management LLC | 53,359 | $687,000 | 0.80% |
| PRICE MICHAEL F | 520,000 | $6,692,000 | 0.74% |